Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021
Open Access
- 17 February 2024
- journal article
- research article
- Published by Maad Rayan Publishing Company in International Journal of Health Policy and Management
- Vol. 13, 7919
Abstract
Background: The health system performance assessment is a challenging process for decision-makers. In case of Kazakhstan's healthcare system, the calculation of avoidable mortality, which has been underutilized to date, could serve as an additional tool to prioritize areas for improvement. Therefore, the aim of the study is to analyse avoidable mortality in Kazakhstan. Methods: The data was retrieved from the Bureau of National Statistics, Kazakhstan. It covers population data by age, mortality rates from disease groups based on the Joint OECD/Eurostat classification of preventable and treatable causes of mortality. The data spans from 2015 to 2021, categorized by gender and 5-year age groups (0, 1–4, 5–9, ..., 70–74). Standardization was performed using the 2015 OECD standard population. We used joinpoint regression analysis to calculate the average annual percentage change. Results: From 2015 to 2019, the annual percentage change in avoidable mortality per 100000 population was -3.8 (-5.7 to -1.8), and from 2019 to 2021 it increased by 17.6 (11.3 to 24.3). Males exhibited higher avoidable mortality rates compared to females. The preventable mortality rate was consistently higher than the treatable mortality. Both preventable and treatable mortality decreased from 2015 to 2019, with preventable mortality reaching 272.17 before rising to 379.23 per 100000 population in 2021. Between 2015 and 2021, treatable mortality rates increased from 179.3 (176.93- 181.67) to 205.45 (203.08-207.81) per 100000 population. Conclusion: In Kazakhstan, the leading causes of avoidable mortality were circulatory diseases, respiratory diseases, and cancer. To achieve the goals of Universal Health Coverage and improve the overall population health, there is an urgent need to amend the healthcare system and reduce avoidable mortality. While it is important to acknowledge the influence of COVID-19 on these trends, our study's focus on avoidable mortality provides valuable insights that complement the understanding of pandemic-related effects.Keywords
This publication has 27 references indexed in Scilit:
- Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21The Lancet, 2022
- How to measure premature mortality? A proposal combining “relative” and “absolute” approachesPopulation Health Metrics, 2021
- Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patientsBMC Infectious Diseases, 2021
- Avoidable deaths in Sweden, 1997–2018: temporal trend and the contribution to the gender gap in life expectancyBMC Public Health, 2021
- Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort studyThe Lancet, 2020
- Impact of the COVID-19 pandemic on life expectancy in Madrid (Spain)Journal of Public Health, 2020
- Comparing trends in mortality from cardiovascular disease and cancer in the United Kingdom, 1983–2013: joinpoint regression analysisPopulation Health Metrics, 2017
- Applications and limitations of the concept of ‘avoidable mortality’ among immigrant groups in Europe: a scoping reviewPublic Health, 2015
- 'Avoidable' mortality: a measure of health system performance in the Czech Republic and Slovakia between 1971 and 2008Health Policy and Planning, 2012
- Variations in amenable mortality—Trends in 16 high-income nationsHealth Policy, 2011